|
|
Volumn 36, Issue 1, 2011, Pages 73-77
|
|
The predicting factors for clinical outcomes in patients with Hürthle cell carcinoma: How we do it
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IODINE 131;
RADIOACTIVE IODINE;
THYROGLOBULIN;
THYROTROPIN;
ADJUVANT THERAPY;
ADULT;
AGED;
ASPIRATION BIOPSY;
CANCER ADJUVANT THERAPY;
CANCER GROWTH;
CANCER INVASION;
CANCER PATIENT;
CANCER SURVIVAL;
CLINICAL ARTICLE;
FEMALE;
FOLLOW UP;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
HURTHLE CELL CARCINOMA;
LETTER;
LYMPH NODE DISSECTION;
LYMPH NODE METASTASIS;
MALE;
PRIORITY JOURNAL;
SUBTOTAL THYROIDECTOMY;
THYROGLOBULIN BLOOD LEVEL;
THYROID FOLLICULAR CARCINOMA;
THYROID SCINTISCANNING;
THYROIDECTOMY;
THYROTROPIN BLOOD LEVEL;
TREATMENT OUTCOME;
ADENOMA, OXYPHILIC;
ADULT;
AGED;
DISEASE PROGRESSION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INCIDENCE;
MALE;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
PROGNOSIS;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SURVIVAL RATE;
THYROID NEOPLASMS;
THYROIDECTOMY;
TURKEY;
YOUNG ADULT;
|
|
EID: 79952747229
PISSN: 17494478
EISSN: 17494486
Source Type: Journal
DOI: 10.1111/j.1749-4486.2011.02212.x Document Type: Letter |
|
Times cited : (6)
|
|
References (10)
|
